Anna Borodovsky
Login to view DISC.Anna Borodovsky is the Vice President of Research at Alnylam Pharmaceuticals, where she has worked since 2006. With a PhD from Harvard University, she leads the companys preclinical liver pipeline, playing a key role in the development of several RNAi therapeutic programs from target nomination to first-in-human studies.
Anna is passionate about the real-world impact of her work, expressing great satisfaction in seeing therapies reach patients. She takes pleasure in supporting patient communities, particularly for conditions like Huntingtons Disease, and celebrates drug approvals that improve the lives of those with neurological and rare diseases.
She has been involved with some research programs, like cemdisiran, for over a decade, from initial stages to successful Phase 3 data.
Read the full overview →How Anna shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Anna cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Alnylam Pharmaceuticals Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.